The Company also reported that all other proposals presented at the Annual Meeting were approved including re-election of its Board of Directors and ratification of the appointment of BDO Seidman, LLP, as the Company's independent registered public accounting firm.
CardioDynamics (Nasdaq: CDIC), the ICG Company, is the innovator and leader of an important medical technology called BioZ(R) Impedance Cardiography (ICG). The Company develops, manufactures and markets noninvasive BioZ(R) ICG products. The Company's BioZ(R) ICG Systems are being used by physicians around the world to help battle the number one killer of men and women -- cardiovascular disease. Partners include GE Healthcare, Philips Medical Systems, and Mindray. For additional information, please refer to the company's Web site at http://www.cdic.com.
Forward-Looking (Safe Harbor) Statement:
Except for the historical and factual information contained herein,
this press release contains forward-looking statements, such as those
relating to future growth and positive cash flows, the timing for the
effectiveness of the reverse split, the anticipated increase in the per
share trading price of the stock, and the Company's ability to regain
compliance with NASDAQ listing standards and remain listed on NASDAQ, the
accuracy of which is necessarily subject to uncertainties and risks
including the Company's sole dependence
Copyright©2008 PR Newswire.
All rights reserved